The best indicator for Ventas (VTR)
We backtested 366 indicators across daily, weekly and hourly charts on real Ventas (VTR) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
TEMA 20/50 Cross
On the weekly chart, this is the strongest risk-adjusted edge we found for Ventas (VTR) over ~29.2 years — beating buy-and-hold by 3.8% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for Ventas (VTR) — trailing buy-and-hold by 1.2% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | TEMA 20/50 Cross ✓ | Weekly | 13.9% | 0.76 | -31.4% | 62.1% | 29 | 3.8% |
| 2 | Williams %R (50) ✓ | Weekly | 13.4% | 0.7 | -48.9% | 39.4% | 33 | 3.4% |
| 3 | T3 8/21 Cross ✓ | Weekly | 13.8% | 0.69 | -48.2% | 61.5% | 26 | 3.8% |
| 4 | Chandelier Exit ✓ | Weekly | 15.1% | 0.68 | -59.7% | 60.0% | 40 | 5.1% |
| 5 | EMA 9/26 Cross ✓ | Weekly | 12.6% | 0.66 | -44.1% | 44.4% | 18 | 2.6% |
| 6 | SMA 50/200 Cross ✓ | Daily | 12.4% | 0.64 | -45.2% | 55.6% | 18 | 2.8% |
| 7 | Ichimoku TK Cross ✓ | Weekly | 12.7% | 0.64 | -64.4% | 56.7% | 30 | 2.7% |
| 8 | Ease of Movement ✓ | Weekly | 13.0% | 0.64 | -66.1% | 54.7% | 64 | 2.9% |
| 9 | Ulcer Index | Weekly | 9.6% | 0.64 | -44.9% | 52.4% | 42 | -0.4% |
| 10 | Williams %R (28) ✓ | Weekly | 12.2% | 0.64 | -56.1% | 47.3% | 55 | 2.2% |
| 11 | CCI (50) ✓ | Weekly | 11.7% | 0.64 | -50.0% | 44.8% | 29 | 1.7% |
| 12 | TRIMA 30 Trend ✓ | Weekly | 11.1% | 0.64 | -43.4% | 55.3% | 38 | 1.1% |
| 13 | WMA 15/60 Cross ✓ | Weekly | 11.5% | 0.63 | -54.3% | 60.0% | 15 | 1.5% |
| 14 | Bollinger Squeeze ✓ | Weekly | 8.7% | 0.62 | -31.0% | 60.0% | 20 | -1.4% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Ventas (VTR), TEMA 20/50 Cross on the weekly timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.